GSK plc
CIK: 1131399SEC EDGAR →
Portfolio Value
$599.2B
Holdings
13
As of
Q1 2026
New Positions
13
Closed Positions
0
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | CRISPR THERAPEUTICS AG | 3,220,627 | $153.2B | 25.57% |
| 2 | WAVE LIFE SCIENCES LTD | 18,245,691 | $132.3B | 22.08% |
| 3 | BIONTECH SE | 889,824 | $79.1B | 13.20% |
| 4 | VIR BIOTECHNOLOGY INC | 8,550,954 | $76.6B | 12.79% |
| 5 | IDEAYA BIOSCIENCES INC | 1,333,333 | $44.4B | 7.41% |
| 6 | LYELL IMMUNOPHARMA INC | 1,512,659 | $30.3B | 5.06% |
| 7 | CYTOKINETICS INC | 340,434 | $22.4B | 3.74% |
| 8 | SPERO THERAPEUTICS INC | 9,190,606 | $21.5B | 3.59% |
| 9 | FULCRUM THERAPEUTICS INC | 1,785,714 | $13.7B | 2.29% |
| 10 | CVRX INC | 1,007,583 | $9.5B | 1.59% |
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 13 | $599.2B | 100.0% |